Johnson & Johnson as of June 30, 2026
Portfolio Holdings for Johnson & Johnson
Johnson & Johnson holds 15 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Protagonist Therapeutics (PTGX) | 37.6 | $300M | 2.4M | 122.58 | |
| Nanobiotix Sponsored Ads (NBTX) | 26.5 | $212M | 5.6M | 37.70 | |
| Meiragtx Holdings (MGTX) | 11.2 | $90M | 6.6M | 13.51 | |
| Rapport Therapeutics (RAPP) | 9.3 | $74M | 1.8M | 41.67 | |
| Contineum Therapeutics Cl A (CTNM) | 4.1 | $32M | 2.0M | 16.39 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 2.9 | $24M | 815k | 28.88 | |
| CVRX (CVRX) | 2.6 | $21M | 4.0M | 5.14 | |
| Xencor (XNCR) | 1.5 | $12M | 748k | 16.10 | |
| Cerebras Systems Com Cl A (CBRS) | 1.5 | $12M | 54k | 221.00 | |
| Fate Therapeutics (FATE) | 1.1 | $9.1M | 3.4M | 2.70 | |
| Procept Biorobotics Corp (PRCT) | 1.0 | $8.1M | 358k | 22.58 | |
| Neumora Therapeutics (NMRA) | 0.4 | $3.1M | 1.8M | 1.70 | |
| Vor Biopharma Com New (VOR) | 0.1 | $989k | 54k | 18.41 | |
| D Fluidigm Corp Del (LAB) | 0.0 | $257k | 312k | 0.82 | |
| Adicet Bio Com New (ACET) | 0.0 | $197k | 23k | 8.64 |
